ARVO Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Liu, C.
Invest Ophthalmol Vis Sci 2007;48: E-Abstract 2090.
© 2007 ARVO


2090—B699

Refractive Error in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): Risk of Late AMD and 5-Year Changes

C. Liu, M. Maguire, G.-S. Ying and CAPT Research Group

Scheie Eye Institute, Philadelphia, Pennsylvania

Commerical Relationships: C. Liu, None; M. Maguire, None; G. Ying, None.

Support: Supported by NIH grant EY 12279, EY 12211.

Abstract

Purpose:To describe refractive error (RE) at baseline, examine RE as a risk factor for late age-related macular degeneration (AMD), and describe 5-year changes in RE among patients with bilateral large drusen.

Methods:1052 participants with ≥10 large (>125µ) drusen and visual acuity ≥20/40 in each eye were enrolled into CAPT. One eye of each participant was randomly assigned to treatment, and the contralateral eye was assigned to observation. RE was measured following a standardized protocol at baseline, 6 months and annually. The association of baseline spherical equivalent (SE) and incident choroidal neovascularization (CNV) and endpoint geographic atrophy (GA) was evaluated through survival analysis. Endpoint GA was defines defined as a total of >1 MPS disc area of atrophy when all areas of geographic atrophy were combined. Associations of demographic and clinical factors with 5-year changes in SE were examined with multiple linear regression analysis. The generalized estimating equations (GEE) approach was used to account for the correlation between eyes of the same subject.

Results:Of the 2084 eyes (excluding 20 eyes with baseline CNV), the mean SE was 0.72± 1.81 D; 1125 (54.0%) were hyperopic (>0.5D), 566 (27.2%) were emmetropic, and 393 (18.9%) were myopic (<-0.5D) at baseline. After adjustment for other risk factors, the relative hazard {95% CI} associated with +1 D was 1.04 ({0.97, 1.12}; p=0.26) for CNV and 0.96 ({0.87, 1.06}; p=0.39) for GA. Among the 1502 eyes with RE measured at 5 years, the mean change was 0.02±0.95D and did not differ between treated (0.04±0.96D) and observed (-0.005±0.95) eyes (p=0.27). Overall, 5 year-changes were more towards hyperopia in males (mean +0.10D) than in females (mean -0.03D; p<0.01). The relation between age and 5-year change depended on lens status (p for interaction <0.005). Among eyes phakic at baseline, older baseline age was associated with an increased myopic shift, while among pseudophakic eyes older baseline age was associated with increased hyperopic shift. For example, among patients older than 75, phakic eyes had SE decrease by 0.24D, but pseudophakic eyes increased by 0.29D.

Conclusions:Among CAPT participants, baseline SE was not associated with incidence of CNV or endpoint GA. SE increased on average by 0.02D in 5 years. Older eyes with a natural lens experienced a myopic shift. Pseudophakic older eyes experienced a hyperopic shift.

Keywords: refractive error development • age-related macular degeneration

© 2007, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH